Skip to content
2000
Volume 15, Issue 2
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873

Abstract

Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) is commonly used as a spice, food additive or dietary pigment. Accumulating evidence suggests that curcumin has several pharmacologic effects, including anti-inflammatory, anti-oxidant and anti-cancer activities. The molecular mechanisms underlying the targets of curcumin are diverse and involve combinations of multiple signaling pathways, including NF-ΚB and STAT3 signaling. Thus, curcumin is one of the most promising phytochemicals that target various cancers and inflammation-mediated diseases. Clinical trials have been ongoing or completed for various cancers, including breast, pancreatic and colorectal cancers, and multiple myeloma. In this review, the molecular mechanisms and the issue of bioavailability are mainly discussed.

Loading

Article metrics loading...

/content/journals/emiddt/10.2174/1871530315666150316120458
2015-06-01
2025-02-08
Loading full text...

Full text loading...

/content/journals/emiddt/10.2174/1871530315666150316120458
Loading

  • Article Type:
    Research Article
Keyword(s): Bioavailability; cancer; curcumin; inflammation; NF-ΚB; rupture
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test